C. diff colitis is inflammation of a person’s colon due to contagious bacteria. Most people with C. diff colitis fully recover, but in rare cases the condition can be life threatening. It is possible ...
Risk for Clostridioides difficile (C. diff) infection wasn't any greater with vedolizumab (Entyvio) versus anti-tumor necrosis factor (TNF) agents for ulcerative colitis, a researcher reported. In a ...
Fecal microbiota transplantation has become one of the most effective treatments for recurrent Clostridioides difficile infections, but its long-term role in gastroenterology may hinge on moving ...
Clostridium difficile infections elevate the risks for colectomy, mortality and postoperative complications after a colectomy for patients with ulcerative colitis, according to NEJM Journal Watch.
Fever, nausea, cramping, and diarrhea — if you have ulcerative colitis (UC), you probably know that those symptoms signal a flare. The same symptoms can also be a Clostridioides difficile (C. diff) ...
Testing for Clostridium difficile infection is significantly lower than expected during diagnosis of inflammatory bowel disease, according to a study in Inflammatory Bowel Diseases, the official ...
A fecal microbiota transplant (FMT) not only cured a case of Clostridium difficile (C. diff) infection in a 66 year old man; it eliminated populations of multi-drug resistant organisms both in the ...
Doctors usually prescribe antibiotics for certain types of colitis, such as ulcerative colitis and ischemic colitis. While antibiotics help with symptoms, there may be some adverse effects. Colitis ...
Which Tests Check for Ulcerative Colitis Remission? Alan Moss, MD, chief scientific officer of the Crohns & Colitis Foundation, defines the types of ulcerative colitis remission, and lists the tests ...
SAN DIEGO -- Patients with moderate to severe ulcerative colitis experienced clinical, endoscopic, histological, and biological improvements with the first-in-class interleukin (IL)-7 receptor ...
How Long Can Ulcerative Colitis Remission Last? Alan Moss, MD, chief scientific officer of the Crohns & Colitis Foundation, lays out the various potential durations of remission from ulcerative ...